e-learning
resources
Munich 2006
Tuesday 05.09.2006
Hypoxic and inflammatory insults to the pulmonary circulation.
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Pulmonary hypertension in chronic obstructive pulmonary disease: the role of cigarette smoking
A. Gaballo, G. M. Corbo, C. Colizzi, L. Paladini, G. Pasciuto, V. Rizzello, F. Pennestri, G. Ciappi, S. Valente (Rome, Italy)
Source:
Annual Congress 2006 - Hypoxic and inflammatory insults to the pulmonary circulation.
Session:
Hypoxic and inflammatory insults to the pulmonary circulation.
Session type:
Thematic Poster Session
Number:
3819
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Gaballo, G. M. Corbo, C. Colizzi, L. Paladini, G. Pasciuto, V. Rizzello, F. Pennestri, G. Ciappi, S. Valente (Rome, Italy). Pulmonary hypertension in chronic obstructive pulmonary disease: the role of cigarette smoking. Eur Respir J 2006; 28: Suppl. 50, 3819
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
The definition of pulmonary hypertension: history, practical implications and current controversies
Related content which might interest you:
Pulmonary hypertension in patients with combined pulmonary fibrosis and emphysema syndrome
Source: Eur Respir J 2010; 35: 105-111
Year: 2010
Characterization of pulmonary vascular remodelling in smokers and patients with mild COPD
Source: Eur Respir J 2002; 19: 632-638
Year: 2002
Epidemiology of chronic obstructive pulmonary disease
Source: Eur Respir J 2001; 17: 982-994
Year: 2001
Pulmonary hypertension frequency in patients with chronic obstructive pulmonary disease exposed to biomass or tobacco smoke
Source: Annual Congress 2012 - Pulmonary circulation: clinical aspects of PAH and associated PH
Year: 2012
The role smoking in development of dust-indusde chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2004; 24: Suppl. 48, 608s
Year: 2004
Pulmonary hypertension associated with chronic obstructive pulmonary disease
Source: Eur Respir J 2006; 28: Suppl. 50, 656s
Year: 2006
Airway inflammation persists after smoking cessation in chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2001; 18: Suppl. 33, 249s
Year: 2001
Chronic obstructive pulmonary disease in smokers with asthma
Source: Annual Congress 2011 - Respiratory epidemiology: prevalence, incidence and remission
Year: 2011
Pulmonary function in patients with chronic obstructive pulmonary disease (COPD) and smoking cessation in exposed to low-dose radiation
Source: Annual Congress 2008 - Lung function in respiratory disease
Year: 2008
Can ADMA play a role in determining pulmonary hypertension related to chronic obstructive lung disease?
Source: International Congress 2016 – Pulmonary hypertension in lung disease
Year: 2016
Systemic vascular function in chronic obstructive pulmonary disease
Source: Annual Congress 2013 –Pulmonary circulation: clinical diagnosis, imaging, biomarkers and treatment
Year: 2013
Effects of smoking cessation in COPD
Source: Annual Congress 2006 - Smoking and COPD: will it ever vanish into smoke?
Year: 2006
Pulmonary arterial hypertension in the patients with chronic obstructive pulmonary disease
Source: Eur Respir J 2005; 26: Suppl. 49, 512s
Year: 2005
Impact of exacerbations on pulmonary arterial enlargement in patients with chronic obstructive pulmonary disease
Source: Annual Congress 2013 –Pulmonary circulation: clinical science and treatment
Year: 2013
Evidence of renal and pulmonary endothelial dysfunction in chronic obstructive pulmonary disease (COPD)
Source: International Congress 2016 – New signalling pathways in COPD
Year: 2016
Smoking abstinence in patients with chronic airway obstructive disease
Source: Annual Congress 2006 - How to treat tobacco smokers
Year: 2006
Tobacco use in relation to COPD and asthma
Source: Eur Respir J 2007; 29: 438-445
Year: 2007
Conclusion: treatment of pulmonary hypertension in COPD patients
Source: Annual Congress 2005 - COPD - pulmonary haemodynamics and gas exchange
Year: 2005
Overview of smoking-related disease
Source: Research Seminar 2006 - Complexity of patients with multiple chronic diseases
Year: 2006
Survival of patients with severe chronic obstructive pulmonary disease in relation to smoking habits
Source: Annual Congress 2012 - Tobacco dependence and respiratory disease
Year: 2012
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept